GE Healthcare Technologies Inc. on Thursday topped analysts' expectations for adjusted profit as its business benefited from growth in its ultrasound imaging products and diagnostic drug products. GE ...

There's still plenty of time for growth investors to click the buy button on Tempus AI stock; however, it's critical to recognize the road ahead may be rocky. Therefore, only those comfortable with an ...

A variety of different initiatives have been created and implemented across the U.S. around value-based contracting; they are ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Management emphasized three strategic priorities for 2025: driving mid-single-digit revenue growth, managing costs with a target of 86% for cost of services and 8.5%-9.5% for SG&A, and optimizing cash ...

Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (”Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S.,today issued a letter to stockholders from Kimball ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

Johnson Controls is well-positioned with a robust $13.2 billion backlog and AI-driven solutions. Read what makes JCI stock an ...

The California Department of Corrections and Rehabilitation (CDCR), California Correctional Health Care Services (CCHCS), and the Department of ...

After a rough 2024, Teladoc Health (TDOC) has seen its shares surge up roughly 45% year-to-date, catalyzed by a recent ...

Her past experience also includes executive roles at Optum, Dallas-based Steward Health Care and Accretive Health (now R1 RCM), according to the release. She has led revenue cycle teams through ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...